managing cns disease in alk-rearranged nsclc
Published 4 years ago • 188 plays • Length 8:30Download video MP4
Download video MP3
Similar videos
-
8:02
updates informing the management of alk-rearranged mnsclc
-
2:30
cns disease in alk-positive nsclc: monitoring and systemic vs. radiation therapy
-
1:22:33
management of alk rearranged nsclc.
-
1:08:32
management of alk rearranged nsclc in first line.
-
1:18:39
management of first line alk rearranged nsclc
-
58:23
management of first-line alk rearranged nsclc
-
3:55
treatment considerations in alk/ros-1–rearranged nsclc
-
4:28
changing the treatment paradigm for alk-rearranged nsclc
-
7:02
crizotinib for alk-rearranged nsclc
-
1:21:44
management of first line alk rearranged nsclc. icon
-
6:37
ascend-4: upfront ceritinib in alk-rearranged nsclc
-
7:03
sequencing therapies for alk-rearranged nsclc
-
8:56
sequencing therapies in alk-rearranged nsclc
-
3:54
sequencing therapies in alk nsclc
-
3:13
available therapies for alk-rearranged nsclc
-
0:59
dr. johung on prognosis of patients with alk-rearranged nsclc and brain metastases
-
8:16
alta ii trial of brigatinib in alk-rearranged nsclc
-
8:15
alex trial: frontline therapy for alk-rearranged nsclc
-
3:15
ros1 rearrangements in mnsclc